Scale Smarter: How Global Supply Chain Centers Amplify CGT Program Growth

For cell and gene therapy (CGT) programs, scaling efficiently is often jeopardized by managing a fragmented network of vendors for cryopreservation, biostorage, and logistics. Each additional handoff introduces risk and operational friction that can derail clinical timelines and complicate compliance across a global network.

A fully integrated, end-to-end supply chain platform can eliminate this complexity. By bringing services—like cryopreservation, biostorage, logistics support, and consulting—together under one roof, programs benefit from fewer touchpoints and streamlined, consistent workflows. This co-location of services ensures materials move securely within a cohesive Chain of Compliance platform, allowing teams to focus on execution rather than vendor coordination.

This integrated approach helps programs scale smarter by providing the operational consistency and flexibility needed for growth. You gain a predictable, repeatable process, from standardized cryopreservation to just-in-time delivery, which minimizes risk and supports a smoother transition from early-phase trials to commercial launch.

Learn how to convert logistical complexity into a strategic advantage and build a resilient supply chain that’s designed for faster, more compliant scaling.